17-45996523-A-G

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_001377265.1(MAPT):ā€‹c.1857A>Gā€‹(p.Ala619=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.191 in 1,600,658 control chromosomes in the GnomAD database, including 32,929 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.15 ( 2153 hom., cov: 31)
Exomes š‘“: 0.20 ( 30776 hom. )

Consequence

MAPT
NM_001377265.1 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10O:1

Conservation

PhyloP100: -3.43
Variant links:
Genes affected
MAPT (HGNC:6893): (microtubule associated protein tau) This gene encodes the microtubule-associated protein tau (MAPT) whose transcript undergoes complex, regulated alternative splicing, giving rise to several mRNA species. MAPT transcripts are differentially expressed in the nervous system, depending on stage of neuronal maturation and neuron type. MAPT gene mutations have been associated with several neurodegenerative disorders such as Alzheimer's disease, Pick's disease, frontotemporal dementia, cortico-basal degeneration and progressive supranuclear palsy. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 17-45996523-A-G is Benign according to our data. Variant chr17-45996523-A-G is described in ClinVar as [Benign]. Clinvar id is 98207.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr17-45996523-A-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=-3.43 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.215 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
MAPTNM_001377265.1 linkuse as main transcriptc.1857A>G p.Ala619= synonymous_variant 9/13 ENST00000262410.10 NP_001364194.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
MAPTENST00000262410.10 linkuse as main transcriptc.1857A>G p.Ala619= synonymous_variant 9/131 NM_001377265.1 ENSP00000262410 A2

Frequencies

GnomAD3 genomes
AF:
0.147
AC:
22120
AN:
150680
Hom.:
2155
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0504
Gnomad AMI
AF:
0.278
Gnomad AMR
AF:
0.177
Gnomad ASJ
AF:
0.241
Gnomad EAS
AF:
0.00160
Gnomad SAS
AF:
0.0752
Gnomad FIN
AF:
0.0667
Gnomad MID
AF:
0.223
Gnomad NFE
AF:
0.218
Gnomad OTH
AF:
0.186
GnomAD3 exomes
AF:
0.145
AC:
35916
AN:
248312
Hom.:
3452
AF XY:
0.148
AC XY:
19960
AN XY:
134616
show subpopulations
Gnomad AFR exome
AF:
0.0482
Gnomad AMR exome
AF:
0.119
Gnomad ASJ exome
AF:
0.254
Gnomad EAS exome
AF:
0.000655
Gnomad SAS exome
AF:
0.0760
Gnomad FIN exome
AF:
0.0678
Gnomad NFE exome
AF:
0.212
Gnomad OTH exome
AF:
0.175
GnomAD4 exome
AF:
0.196
AC:
283520
AN:
1449850
Hom.:
30776
Cov.:
53
AF XY:
0.193
AC XY:
139237
AN XY:
721366
show subpopulations
Gnomad4 AFR exome
AF:
0.0444
Gnomad4 AMR exome
AF:
0.126
Gnomad4 ASJ exome
AF:
0.258
Gnomad4 EAS exome
AF:
0.000898
Gnomad4 SAS exome
AF:
0.0797
Gnomad4 FIN exome
AF:
0.0797
Gnomad4 NFE exome
AF:
0.223
Gnomad4 OTH exome
AF:
0.179
GnomAD4 genome
AF:
0.147
AC:
22110
AN:
150808
Hom.:
2153
Cov.:
31
AF XY:
0.138
AC XY:
10132
AN XY:
73648
show subpopulations
Gnomad4 AFR
AF:
0.0503
Gnomad4 AMR
AF:
0.177
Gnomad4 ASJ
AF:
0.241
Gnomad4 EAS
AF:
0.00161
Gnomad4 SAS
AF:
0.0752
Gnomad4 FIN
AF:
0.0667
Gnomad4 NFE
AF:
0.218
Gnomad4 OTH
AF:
0.183
Alfa
AF:
0.203
Hom.:
3777
Bravo
AF:
0.151
Asia WGS
AF:
0.0320
AC:
112
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:10Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:6
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, Amsterdam University Medical Center-- -
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsFeb 25, 2011- -
not provided Benign:2Other:1
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxAug 11, 2018- -
not provided, no classification providedliterature onlyVIB Department of Molecular Genetics, University of Antwerp-- -
MAPT-Related Spectrum Disorders Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Frontotemporal dementia Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.66
DANN
Benign
0.62

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1052553; hg19: chr17-44073889; API